On Friday 27 November, the LIFE Cooperative is organising LIFE Compliance Day 2026. The day will be entirely dedicated to current compliance issues, knowledge-sharing and networking within our community on the topic of sustainability in medtech.
The programme begins in the morning with an official opening by the LIFE Cooperative Compliance Working Group, followed by an in-depth workshop led by the UMCG. During lunch, there will be an opportunity to continue discussions with other participants.
The afternoon will focus on the main RAPS NL programme, featuring international perspectives and best practices. We will round off the day with a networking reception, where there will be plenty of opportunity to exchange experiences and make new contacts.
We look forward to welcoming you to this inspiring day!
You can register for the LIFE Compliance Day using the form on this page. Participation in the morning programme, including lunch and the networking drinks reception, is free of charge.
Would you also like to take part in the special RAPS programme in the afternoon?
If so, you can register for this separately; registration for this will open closer to the event.
With more than 3,000 Life Sciences & Health R&D companies, 13 universities, 2,100+ ongoing clinical trials, 104,000+ employees, and an export value of €50 billion, the Netherlands is a major player in the European life sciences industry, boasting a strong technological position in areas such as human vaccines, biopharmaceuticals, and healthcare infrastructure. The Dutch sector owes this position to collaboration, cooperation, and coalition building between companies, research institutes, and universities.
Every year, the LIFE Cooperative attends BIO Europe, bringing together various companies to this global trade fair. BIO Europe Fall connects Europe's leading innovation centers with the global life sciences industry to develop thriving strategic partnerships. Interested in participating or need more information? Fill out the form below!
After years of innovation and collaboration in personalised implant technology, we are excited to invite researchers, clinicians, industry partners, and healthcare innovators to the iMPaCT-Implants Closing Event.
